Table 5.
Organisms Causing Invasive Fungal Disease by Study Group
| Caspofungin (n = 144) | Combined Triazole (n = 146) | Fluconazole (n = 100) | Voriconazole (n = 46) | |
|---|---|---|---|---|
| By day 42 | ||||
| Proven | 2 | 1 | 1 | 0 |
| Candida glabrata | 1 | 0 | 0 | 0 |
| Aspergillus spp. | 0 | 0 | 0 | 0 |
| Other fungia | 1 | 1 | 1 | 0 |
| Probable | 0 | 1 | 0 | 1 |
| Candida spp. | 0 | 0 | 0 | 0 |
| Aspergillus spp. | 0 | 0 | 0 | 0 |
| Other fungib | 0 | 1 | 0 | 1 |
| Day 43–100 | ||||
| Proven | 1 | 1 | 1 | 0 |
| Candida lusitaniae | 0 | 1 | 1 | 0 |
| Aspergillus spp. | 0 | 0 | 0 | 0 |
| Rhizopus spp. | 1 | 0 | 0 | 0 |
| Probable | 1 | 2 | 2 | 0 |
| Candida spp. | 0 | 0 | 0 | 0 |
| Aspergillus spp.c | 1 | 1 | 1 | 0 |
| Other fungib | 0 | 1 | 1 | 0 |
Abbreviation: NOS, not otherwise specified.
aMold NOS (caspofungin arm) and mold NOS (fluconazole arm).
bFungus NOS.
c Aspergillus NOS.